江苏康禾生物

Jiangsu Kanghe Biological Technology Co., Ltd. is a Chinese biotechnology company focused on the research, development, and production of high-end pharmaceutical intermediates and active pharmaceutical ingredients (APIs). The company specializes in peptide synthesis and recombinant protein technologies, particularly targeting metabolic diseases such as diabetes and obesity. Kanghe Biological operates a large-scale manufacturing facility in Jiangsu province, providing high-purity raw materials for the global pharmaceutical industry. Their product portfolio includes various GLP-1 receptor agonists and other peptide-based therapeutics. The company integrates R&D with industrial-scale production to support both domestic and international drug development pipelines.